Skip to content

Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital

Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210628003
Enrollment
295
Registered
2021-06-28
Start date
2019-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital microbial contamination multiple dose eye drops anti-infective eye drops preservative-free hospital ophthalmic preparation

Interventions

Eye drops samples in the study were cultured in chocolate agar, blood agar and sabouraud dextrose agar
Experimental Other
Eye drops samples cultured

Sponsors

Rajavithi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients, regardless of diagnosis, who used topical anti-infective medications, preservative-free and multiple-use eye drops only, prepared by Rajavithi Hospital. The hospital-made preservative-free eye drops included: antibiotics Amikacin 50mg/ml, Ceftazidime 50mg/ml, Cefazolin 50mg/ml, Vancomycin 50mg/ml; antifungals Amphoterincin B 1.7mg/ml, Natamycin 50mg/ml, Voriconazole 10mg/ml.

Exclusion criteria

Exclusion criteria: Bottles used for fewer than 2 days or which had passed their expiry date were excluded

Design outcomes

Primary

MeasureTime frame
Positive culture 1 month Culture result from eye drops sample

Secondary

MeasureTime frame
factor related to contamination 1 month patients factor

Countries

Thailand

Contacts

Public ContactSomporn Chantra

Rajavithi Hospital

chantrasomporn@yahoo.com0865413765

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026